Cargando…
S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428409/ http://dx.doi.org/10.1097/01.HS9.0000967892.54405.ff |
| _version_ | 1785090462145576960 |
|---|---|
| author | Locatelli, Franco Antmen, Bulent Kang, Hyoung Jin Koh, Katsuyoshi Takahashi, Yoshiyuki Kupesiz, Alphan Matos, Maria Gabriela Wall, Donna Bhat, Sunil Im, Ho Joon Gungor, Tayfun Lu, Meng-Yao Stefanelli, Tommaso Rosko, Christine Pierre, Annie St. Burock, Karin Diaz-De-Heredia, Cristina |
| author_facet | Locatelli, Franco Antmen, Bulent Kang, Hyoung Jin Koh, Katsuyoshi Takahashi, Yoshiyuki Kupesiz, Alphan Matos, Maria Gabriela Wall, Donna Bhat, Sunil Im, Ho Joon Gungor, Tayfun Lu, Meng-Yao Stefanelli, Tommaso Rosko, Christine Pierre, Annie St. Burock, Karin Diaz-De-Heredia, Cristina |
| author_sort | Locatelli, Franco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428409 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284092023-08-17 S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY Locatelli, Franco Antmen, Bulent Kang, Hyoung Jin Koh, Katsuyoshi Takahashi, Yoshiyuki Kupesiz, Alphan Matos, Maria Gabriela Wall, Donna Bhat, Sunil Im, Ho Joon Gungor, Tayfun Lu, Meng-Yao Stefanelli, Tommaso Rosko, Christine Pierre, Annie St. Burock, Karin Diaz-De-Heredia, Cristina Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428409/ http://dx.doi.org/10.1097/01.HS9.0000967892.54405.ff Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Locatelli, Franco Antmen, Bulent Kang, Hyoung Jin Koh, Katsuyoshi Takahashi, Yoshiyuki Kupesiz, Alphan Matos, Maria Gabriela Wall, Donna Bhat, Sunil Im, Ho Joon Gungor, Tayfun Lu, Meng-Yao Stefanelli, Tommaso Rosko, Christine Pierre, Annie St. Burock, Karin Diaz-De-Heredia, Cristina S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title | S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title_full | S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title_fullStr | S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title_full_unstemmed | S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title_short | S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY |
| title_sort | s245: ruxolitinib in pediatric patients with treatment-naive or steroid-refractory chronic graft versus host disease: primary findings from the phase ii reach5 study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428409/ http://dx.doi.org/10.1097/01.HS9.0000967892.54405.ff |
| work_keys_str_mv | AT locatellifranco s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT antmenbulent s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT kanghyoungjin s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT kohkatsuyoshi s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT takahashiyoshiyuki s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT kupesizalphan s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT matosmariagabriela s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT walldonna s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT bhatsunil s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT imhojoon s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT gungortayfun s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT lumengyao s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT stefanellitommaso s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT roskochristine s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT pierreanniest s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT burockkarin s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study AT diazdeherediacristina s245ruxolitinibinpediatricpatientswithtreatmentnaiveorsteroidrefractorychronicgraftversushostdiseaseprimaryfindingsfromthephaseiireach5study |